BioSpace News Archive

Business

Unwilling to Let Muscular Dystrophy Beat Him, Lululemon Founder Commits $100M to Research

Solve FSHD exists to fund biotechnology and biopharmaceutical research and development efforts toward finding a treatment and cure for FSHD.

March 9, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

COVID-19 Update: Pfizer Studying Paxlovid in Kids, Free Antivirals Roll Out

Pfizer has launched a Phase II/III study to assess its oral antiviral Paxlovid in non-hospitalized symptomatic pediatric patients who are at risk for progression to serious disease.

March 9, 2022
·
3 min read
·
Alex Keown
FDA

How the Biopharma Workforce is Shaping the Future

Recent technological advancements have pushed pharma employees to embrace new technologies and innovations in different areas.

March 9, 2022
·
6 min read
·
Alina Zahid
Business

Patient Dies Two Months After Receiving Genetically Altered Pig Heart

Two months after he received a gene-edited pig heart, David Bennett Sr. has died. He was 57.

March 9, 2022
·
3 min read
·
Alex Keown
Drug Development

Akari’s New Antihistamine Shows Promise in Preclinical Hypersensitivity Models

Akari announced that votucalis has potential as a treatment for pain and itch associated with conditions such as atopic dermatitis, psoriasis and neuropathic pain.

March 9, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Business

Kriya and Twist Partner to Transform Cancer Therapy with AAVs

Kriya forged an antibody discovery agreement with Twist to support the delivery of antibodies with AAV gene therapy in therapeutic oncology applications.

March 9, 2022
·
2 min read
·
Alex Keown
Drug Development

AIM ImmunoTech Announces Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the AACR 2022 Annual Meeting

AIM ImmunoTech Inc. announced today that data from the ongoing Phase 2 cisplatin-resistant advanced recurrent ovarian cancer clinical study utilizing Ampligen®.

March 9, 2022
·
5 min read
Business

Syros to Report Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 15, 2022

Syros Pharmaceuticals today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, March 15, 2022 to report its fourth quarter and full year 2021 financial results and provide a corporate update.

March 9, 2022
·
1 min read
Drug Development

Oncolytics Biotech® Announces Upcoming Poster Presentation at the AACR Annual Meeting

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced an upcoming poster presentation that will feature long-term follow-up results from ReoGlio, an investigator-sponsored, phase 1b trial evaluating the combination of pelareorep.

March 9, 2022
·
4 min read
ZYUS Life Sciences Awarded EU-GMP Certification, Enables Expansion into Rapidly Growing Global Medical Cannabinoids Markets

ZYUS Life Sciences Inc., a Canadian-based life sciences company leading scientific research and development in phyto-therapeutics, announced that the company’s Canadian manufacturing facility has been awarded EU-Good Manufacturing Practice certification.

March 9, 2022
·
5 min read